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804-1 18F-Fluoro-2-Deoxyglucose as a Memory Marker of 
Transient Myocardial Ischemia
Brian G. Abbott, Yi-Hwa Liu, James A. Arrighi, Yale University School of Medicine, New 
Haven, CT, VA Connecticut Healthcare System, West Haven, CT
Background: Myocardial uptake of flourine-18 labeled 2-deoxyglucose (FDG) parallels
endogenous glucose uptake. Experimental data have shown that glucose utilization
increases during acute myocardial ischemia in proportion to its severity and duration, and
may persist for up to 24 hours. Whether FDG uptake can be imaged as a memory marker
of ischemia in humans is unknown. Methods: Patients with mild to moderate ischemia on
a clinical exercise SPECT myocardial perfusion imaging (MPI) underwent repeat exercise
testing within 1-2 weeks, to an equivalent workload after overnight fast. Positron emission
tomography (PET) was performed after injection of FDG 60 minutes post exercise.
SPECT and PET images were assessed visually and quantitatively using regions of inter-
est for heart:lung ratios and a circumferential profile-based analysis modified for “hot-
spot” imaging. A change in regional maximal uptake >10% on SPECT and regional FDG
PET uptake >110% was considered as evidence of ischemia. Results: Ten males with
stress SPECT ischemia (mean age 69 years, 7 known coronary artery disease[CAD])
were studied. The mean difference in the rate pressure product between the 2 exercise
tests was 1.5+19%. FDG was injected 66+10 min after exercise. Visually, 5 of 10 patients
had enhanced regional FDG uptake (mean [range] heart:lung ratio 5.3 [3.5-7.8] in visu-
ally abnormal vs. 3.0 [2.5-3.4] without visual uptake, p=0.02 respectively). Using circum-
ferential profiles, 7 patients had maximal FDG uptake >110%; mean FDG uptake in these
regions was 120+12%. Overall, 8 of 10 patients studied had evidence of FDG uptake by
visual and/or quantitative analysis. All patients with a visually and/or quantitatively posi-
tive FDG scan had uptake in either an ischemic SPECT region or a territory with known
CAD by angiography. Conclusion: Regional myocardial uptake of FDG is enhanced
even when injected 1 hour post-exercise stress in a subset of patients with ischemia on
exercise SPECT MPI. Enhanced FDG uptake localized with regional SPECT ischemia
and/or angiographic CAD. The ability to image FDG uptake injected 1 hour after an
ischemic episode suggests the potential utility of FDG as a memory marker of transient
ischemia.
9:30 a.m.
804-2 Efficacy of Lipid Lowering Therapy in Inducing Arrest or 
Reversal of Coronary Disease as Assessed With 
Positron Emission Tomography
Michael E. Merhige, George M. Watson, Joseph G. Oliverio, Victoria Shelton, Shannon 
N. Frank, Anthony F. Perna, State University of New York at Buffalo, Buffalo, NY
Background: PET myocardial perfusion imaging (PET MPI) identifies coronary disease
(CAD) progression and reversal in response to lipid lowering therapy (LLT). Optimal lipid
values necessary to reverse CAD have not yet been identified, however, NCEP ATP-III
(NCEP) guidelines are used as clinical targets in practice. The purpose of this study was
to evaluate the efficacy of aggressive LLT, beyond NCEP guidelines, to induce arrest or
reversal of CAD as assessed with PET MPI.
Methods: 128 patients with iv dipyridamole stress induced myocardial perfusion defects
at baseline, treated for 1.5 years to beyond NCEP guidelines, underwent follow-up PET
MPI and outcome assessments for MI, coronary death, CABG, CVA, and PTCI. Paired
stress PET studies were analyzed with automated software to determine the average
uptake of 82-Rb in the anterior, septal, inferior, lateral and apical segments normalized to
peak myocardial activity. Baseline and follow-up MPI studies were then compared with
the paired t-test, to identify significant improvement, worsening, or stabilization in seg-
mental perfusion in each patient.
Results: With LLT: 30 patients demonstrated improvement in myocardial perfusion, 64
patients no change, and 34 progression of CAD despite treatment. At a mean follow-up
of 7.5 months after the second PET, coronary events occurred in 3.3%, 10.9%, and
17.7% respectively.
Conclusions: PET MPI identifies 26% of patients with progressive CAD, despite LLT,
who have a high-risk of subsequent hard coronary events.
9:45 a.m.
804-3 The Effects of Cardiac Resynchronization Therapy on 
Regional Left and Right Ventricular Energetics and 
Metabolic Reserve in Patients With Dilated 
Cardiomyopathy
Juhani M. Knuuti, Jan Sundell, Erik Engblom, Juhani Koistinen, Antti Ylitalo, Kira Q. 
Stolen, Riikka Kalliokoski, Stephan G. Nekolla, Jeroen J. Bax, Juhani K.E. Airaksinen, 
University of Turku, Turku, Finland
Background: Cardiac resynchronization therapy (CRT) has been found to enhance on
left ventricular (LV) energetics and metabolic reserve in patients with heart failure. The
purpose of the study was to investigate the effects of CRT on regional energetics and
right ventricle (RV).
Methods: Ten patients with idiopathic dilated cardiomyopathy who had undergone
implantation of biventricular pacemaker 8±5 months earlier were studied during 2 condi-
tions: CRT ON and after CRT switched OFF for 24 hours. LV function was measured
using echocardiography and oxidative metabolism using [11C]acetate positron emission
tomography (Kmono) from both LV and RV. Both measurements were performed at rest
and during dobutamine induced stress (5µg/kg/min). Basal and adenosine (140 µg/kg/
min) stimulated myocardial blood flow were quantitated using [15O]water.
Results: As found previously when CRT was turned OFF global myocardial efficiency of
forward work deteriorated significantly. The regional LV Kmono changes were significant
only in the anteroapical regions (p=0.013) while in other regions no changes were seen
(p=0.43). CRT has no effect at rest on RV (ON: 0.052+0.014, OFF 0.047+0.018, ns.) but
during stress oxidative metabolism was more enhanced when CRT was ON (0.076+0.02
vs. 0.065+0.027, p=0.003). No significant effects were seen in myocardial perfusion.
In 5 patients the response to CRT was striking (mean LV stroke volume increase by 32%)
while in the other five no response was seen (+2%). None of the measured parameters
except RV oxidative metabolism were associated with the CRT response. In responders
RV Kmono at rest was lower than in non-responders (0.036+0.01 vs. 0.058+0.02,
p=0.47).
Conclusions: Long term CRT has beneficial effects on LV function and myocardial effi-
ciency in patients with heart failure. However, the change in absolute oxidative metabo-
lism by CRT appears significant only in anteroapical regions of LV. CRT appears to
increase RV oxidative metabolism especially during stress likely indicating changes in RV
loading. The patients responding to CRT appear to have lower RV oxidative metabolism.
This suggests significant role of RV in the response to CRT.
10:00 a.m.
804-4 The Relationship Between Minute Ventilation and the 
Rate of CO2 Elimination Reflects the Right Ventricular 
Oxidative Metabolism in Heart Failure
Heikki Ukkonen, Rob de Kemp, Ross Davies, William Dafoe, Ian Burwash, Haissam 
Haddad, Karen Mostert, May Aung, Terry Ruddy, Rob Beanlands, University of Ottawa 
Heart Institute, Ottawa, ON, Canada
Background: The relationship between minute ventilation and the rate of CO2 elimina-
tion (the VE/VCO2 slope) is strongly related to mortality in patients with congestive heart
failure (CHF) and provides complimentary prognostic information to peak oxygen uptake
(peak VO2). The VE/VCO2 slope has been proposed to reflect pulmonary vascular resis-
tance (PVR) in CHF patients. Therefore, we hypothesized that an increased VE/VCO2
slope would be associated with elevated right ventricular (RV) oxidative metabolism rela-
tive to the left ventricle (LV).
Subjects and methods: 15 patients with CHF (ischemic [n=14], non-ischemic [n=1];
65±10 yrs; BMI 29±5 kg/m2; LVEF 30±8 %; NYHA class 2.5±0.5; all pts on ß-blockers
and ACE-inhibitors) underwent symptom limited cardiopulmonary exercise testing using
a Slow Ramp treadmill protocol. Dynamic 11C-acetate PET was used to simultaneously
measure oxidative metabolism (kmono) for both the left (LV) and right ventricle (RV). Cor-
rected RV oxidative metabolism (RVOx) was calculated as: RVOx = RV/LV kmono ratio.
Results: In the 15 CHF pts, mean exercise time was 7:26±2:03 min. Peak VO2 was
decreased at 16.2±3.9 ml/min/kg and the VE/VCO2 slope was increased at 35.9±4.8 at
anaerobic threshold. The mean kmono was 0.043±0.007 min-1 for the LV and 0.036±0.007
min-1 for the RV. Mean RVOx was 86±17%. There was a good correlation between RVOx
and the VE/VCO2 slope (r=0.63, p=0.013). Exercise parameters did not correlate with LV
oxidative metabolism.
Conclusions: VE/VCO2 slope correlates with RVOx in CHF patients, supporting the
hypothesis that PVR is a determining factor for the VE/VCO2 slope. RVOx derived using
11C-acetate PET may provide a useful prognostic measure in CHF patients.
10:15 a.m.
804-5 Impact of Increased Fatty Acid Delivery on Myocardial 
Fatty Acid Metabolism in Obese Young Women
Linda R. Peterson, Pilar Herrero, Zulia Kisrieva-Ware, Carmen Dence, JoAnn Marsala, 
Robert J. Gropler, Washington University, St. Louis, MO
Background: Obesity is associated with an increased risk of heart failure. We have
shown that myocardial fatty acid utilization (MFAU) and oxidation (MFAO) are increased
in obese young women. Results of studies in animal models of obesity show that high fat
diets further increase myocardial fatty acid (FA) metabolism and esterification (MFAE),
which contributes to cardiac dysfunction over time. Whether increased plasma FA levels
in obese humans cause an increase in myocardial FA metabolism is unknown.
Methods: We studied 6 women (body mass index 40 ± 7 kg/m2, 21-37 yrs) who were
Baseline Follow Up % Change p-value
Total Cholesterol 168 +/- 38 152 +/- 30 - 10.5 0.0001
LDL 95 +/- 36 83 +/- 23 - 12.6 0.0001
HDL 45 +/- 13 49 +/- 14 + 8.9 0.03
Triglyceride 137 +/- 74 105 +/- 59 - 23.4 0.0001
